Charles A. McWherter
2017
In 2017, Charles A. McWherter earned a total compensation of $708.5K as Senior Vice President and Chief Scientific Officer at Cymabay Therapeutics, a 21% increase compared to previous year.
Compensation breakdown
| Bonus | $192,971 |
|---|---|
| Option Awards | $126,800 |
| Salary | $367,563 |
| Other | $21,202 |
| Total | $708,536 |
McWherter received $367.6K in salary, accounting for 52% of the total pay in 2017.
McWherter also received $193K in bonus, $126.8K in option awards and $21.2K in other compensation.
Rankings
In 2017, Charles A. McWherter's compensation ranked 10,556th out of 14,666 executives tracked by ExecPay. In other words, McWherter earned more than 28.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,556 out of 14,666 | 28th |
Division Manufacturing | 4,104 out of 5,772 | 29th |
Major group Chemicals And Allied Products | 1,459 out of 2,075 | 30th |
Industry group Drugs | 1,190 out of 1,731 | 31st |
Industry Pharmaceutical Preparations | 926 out of 1,333 | 31st |
Source: SEC filing on April 20, 2018.
McWherter's colleagues
We found three more compensation records of executives who worked with Charles A. McWherter at Cymabay Therapeutics in 2017.
News
Cymabay Therapeutics CEO Sujal Shah's 2022 pay rises 16% to $2.6M
April 19, 2023
Cymabay Therapeutics CEO Sujal Shah's 2021 pay slips 16% to $2.2M
April 26, 2022
Cymabay Therapeutics CEO Sujal Shah's 2019 pay jumps 32% to $2.6M
May 15, 2020
Cymabay Therapeutics General Counsel Paul Quinlan receives $3M in 2018
April 26, 2019